3.100USD+6.53%Mkt Cap: 1.60M USDP/E: —Last update: 2026-05-26
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal He…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap1.60M USD
Enterprise Value45.02M USD
Revenue (TTM)11.51M USD
Gross Profit7.74M USD
Net Income (TTM)-53.43M USD
Revenue/Share172.73 USD
Last Price3.100 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.61
PEG—
EV/EBITDA-1.04
EV/Revenue3.91
P/S0.15
P/B-0.03
EPS (TTM)-803.95
EPS (Forward)-5.68
52W Range
2.5300% of range171.50
52W High171.50 USD
52W Low2.530 USD
Profitability
Gross Margin67.21%
Oper. Margin-631.90%
EBITDA Margin0.00%
Profit Margin-464.20%
ROE309.06%
ROA-139.43%
Growth
Revenue Growth-7.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.69M USD
CapEx (TTM)41.00K USD
FCF Margin-126.97%
FCF Yield-914.40%
Net Debt42.64M USD
Net Debt/EBITDA-0.99
Balance Sheet
Debt/Equity-2.52
Current Ratio0.50
Quick Ratio0.07
Book Value/Sh-99.2020 USD
Cash/Share2.602 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 7, 2019
Splits
Last Split1:35
Split DateApr 30, 2026
Analyst Consensus
Rating—
Target (Mean)262.50 USD
Target Range262.50 USD – 262.50 USD
# Analysts1
Ownership
Shares Out.513.94K
Float352.76K
Insiders6.38%
Institutions1.22%
Short Interest
Short Ratio5.7d
Short % Float28.91%
Short % Out.28.91%
Shares Short107.54K
Short (prev mo.)13.75K
Technical
SMA 5010.68 (-71.0%)
SMA 20040.37 (-92.3%)
Beta0.03
S&P 52W Chg28.31%
Avg Vol (30d)109.42K
Avg Vol (10d)145.82K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—